HopeStage
Back to all studies
CompletedNCT01881763

Ketamine Compared With Methohexital During ECT for Depression

About this titleRead the official source — NCT01881763
Medication studyAges 18–70United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
Glen OaksSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 2010
Recruitment status
Completed
Enrollment listed in the registry
31
Sponsor
Northwell Health
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT01881763
Official title
Show the full official title

Comparing Therapeutic Efficacy and Cognitive Side Effects of Electroconvulsive Therapy (ECT) Using Ketamine Versus Methohexital Anesthesia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Glen Oaks

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Northwell Health.

Did this study involve medication?

Yes. The study involved medication, including ketamine and Methohexital.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies